Back
Biomarin Pharmaceutical Quote, Financials, Valuation and Earnings
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
57
BMRN
Biomarin Pharmaceutical
Last Price:
62.15
Seasonality Move:
12.47%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Biomarin Pharmaceutical Price Quote
$62.15
-0.41 (-0.66%)
(Updated: November 21, 2024 at 11:00 AM ET)
Biomarin Pharmaceutical Key Stats
Buy
57
Biomarin Pharmaceutical (BMRN)
is a Buy
Day range:
$61.61 - $62.70
52-week range:
$61.40 - $99.56
Dividend yield:
0%
P/E ratio:
71.18
P/S ratio:
4.42
P/B ratio:
2.18%
Volume:
1.2M
Avg. volume:
1.5M
1-year change:
-28.53%
Market cap:
$11.8B
Revenue:
$2.4B
EPS:
$1.67
How Much Does Biomarin Pharmaceutical Make?
-
How Much Are Biomarin Pharmaceutical's Sales Annually?
BMRN Revenues are $2.4B -
How Much Profit Does Biomarin Pharmaceutical's Make A Year?
BMRN net income is $167.6M
Is Biomarin Pharmaceutical Growing As A Company?
-
What Is Biomarin Pharmaceutical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.28% -
What Is Biomarin Pharmaceutical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 1.62%
Biomarin Pharmaceutical Stock Price Performance
-
Did Biomarin Pharmaceutical Stock Go Up Last Month?
Biomarin Pharmaceutical share price went down by -10.77% last month -
Did BMRN's Share Price Rise Over The Last Year?
BMRN share price fell by -28.53% over the past 1 year
What Is Biomarin Pharmaceutical 52-Week High & Low?
-
What Is Biomarin Pharmaceutical’s 52-Week High Share Price?
Biomarin Pharmaceutical has traded as high as $99.56 over the past 52 weeks -
What Is Biomarin Pharmaceutical’s 52-Week Low Share Price?
Biomarin Pharmaceutical has traded as low as $61.40 over the past 52 weeks
Biomarin Pharmaceutical Price To Free Cash Flow
-
Is Biomarin Pharmaceutical Stock Overvalued?
Biomarin Pharmaceutical is trading at a price to free cash flow ratio of 40.41 -
Is Biomarin Pharmaceutical Stock Undervalued?
Biomarin Pharmaceutical EV to Free Cash Flow ratio is 38.11 -
What Is Biomarin Pharmaceutical’s Price Earnings Growth Ratio?
BMRN PEG ratio is 0.32 -
Is Biomarin Pharmaceutical Trading At A Premium To Earnings?
Biomarin Pharmaceutical EV to EBIT ratio is 28.17
Is It Risky To Buy Biomarin Pharmaceutical?
-
How Much Debt Does Biomarin Pharmaceutical Have?
Total long term debt quarterly is $594.6M -
How Much Cash Does Biomarin Pharmaceutical Have?
Cash and short term investments quarterly total is $930.4M -
What Is Biomarin Pharmaceutical’s Book Value Per Share?
Book value per share is 28.41
Is Biomarin Pharmaceutical Cash Flow Positive?
-
What Is BMRN Cash Flow From Operations?
Cash flow from operations (TTM) is $414.7M -
What Is Biomarin Pharmaceutical’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$518.5M -
What Is Biomarin Pharmaceutical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.9M
Biomarin Pharmaceutical Return On Invested Capital
-
Is Management Doing A Good Job?
BMRN return on invested capital is 5.27% -
What Is Biomarin Pharmaceutical Return On Assets?
ROA measures how assets are converting to revenues and is 4.69% -
What Is BMRN Return On Equity?
ROE is a measure of profitability and is 6.29%
Biomarin Pharmaceutical Earnings Date & Stock Price
-
What Is Biomarin Pharmaceutical's Stock Price Today?
A single share of BMRN can be purchased today for 62.56 -
What Is Biomarin Pharmaceutical’s Stock Symbol?
Biomarin Pharmaceutical trades on the nasdaq under the ticker symbol: BMRN -
When Is Biomarin Pharmaceutical’s Next Earnings Date?
The next quarterly earnings date for Biomarin Pharmaceutical is scheduled on February 21, 2025 -
When Is BMRN's next ex-dividend date?
Biomarin Pharmaceutical's next ex-dividend date is November 21, 2024 -
How To Buy Biomarin Pharmaceutical Stock?
You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Biomarin Pharmaceutical Competitors
-
Who Are Biomarin Pharmaceutical's Competitors?
Below is a list of companies who compete with Biomarin Pharmaceutical or are related in some way:
Biomarin Pharmaceutical Dividend Yield
-
What Is BMRN Dividend Yield?
Biomarin Pharmaceutical’s dividend yield currently is 0% -
What Is Biomarin Pharmaceutical’s Payout Ratio?
Biomarin Pharmaceutical’s payout ratio is 0% -
When Did Biomarin Pharmaceutical Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Biomarin Pharmaceutical’s Dividend Per Share?
Biomarin Pharmaceutical pays a dividend of $0.00 per share
Biomarin Pharmaceutical Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 161.91% | 14.73% |
| Revenue: | 28.28% | 6.03% |
Analyst Recommendations
| Buy Recommendations: | 14 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 98.39 |
| Upside from Last Price: | 57.27% |